Inflammation, excacerbation of heart failure, and ventricular tachyarrhythmias in stable heart failure patients with implantable cardioverter-defibrillator.

Inflammation, excacerbation of heart failure, and ventricular tachyarrhythmias in stable heart failure patients with implantable cardioverter-defibrillator. - Biomarkers and ventricular tachyarrhythmias

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30360

Enrollment

100

Registered

2007-01-16

Start date

2007-04-27

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden cardiac death ventricular arrhythmias

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a ClassI/Class II indication for ICD therapy Patient with NYHA Class II and higher

Exclusion criteria

Exclusion criteria: Replacement of a pulsegenerator Permanent atrial fibrillation Life expectancy

Design outcomes

Primary

Measure	Time frame
The association between ventricular arrhythmias and biomarkers (hs-CRP and BNP).	—

Countries

Netherlands

Outcome results